According to the findings of this study, the majority of BSCs had underlying PTCH1 and SMO mutations in addition to mutations in other known BCC drivers such as MYCN, PPP6C, GRIN2A, CSMD3, DCC, PREX2, APC, PTEN, and PIK3CA [30]. This evidence concerns the gene PREX2 and skin basal cell carcinoma.